Durable epigenetic silencing with a TALE-based editor

This publication has 10 references indexed in Scilit:

• Design of optimized epigenetic regulators for durable gene silencing with application to PCSK9 in nonhuman primates
  Nature Biotechnology, 2025
• Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism
  Molecular Therapy - Methods & Clinical Development, 2025
• A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels
  Nature Medicine, 2025
• Durable and efficient gene silencing in vivo by hit-and-run epigenome editing
  Nature, 2024
• Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
  Signal Transduction and Targeted Therapy, 2024
• Lipid nanoparticles for mRNA delivery
  Nature Reviews Materials, 2021
• Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
  Cell, 2021
• Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
  New England Journal of Medicine, 2020
• Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
  Cell, 2016
• Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
  Science, 2009